Nanovaccines, a new generation of vaccines that use nanoparticles as carriers and/or
adjuvants, have been widely used in the prevention and treatment of various diseases …

Cancer vaccines, which have been widely investigated in the past few decades, are one of
the most attractive strategies for cancer immunotherapy. Through the precise delivery of …

Cancer vaccines hold considerable promise for the immunotherapy of solid tumors.
Nanomedicine offers several strategies for enhancing vaccine effectiveness. In particular …

Tumor vaccines aim to activate dormant or unresponsive tumor-specific T lymphocytes by
using tumor-specific or tumor-associated antigens, thus enhancing the body's natural …

Vaccines therapeutics manipulate host's immune system and have broad potential for
cancer prevention and treatment. However, due to poor immunogenicity and limited safety …

The past few decades have witnessed the booming field of cancer immunotherapy. Cancer
therapeutic vaccines, either alone or in combination with other immunotherapies such as …

As an interesting cancer immunotherapy approach, cancer vaccines have been developed
to deliver tumor antigens and adjuvants to antigen-presenting cells (APCs). Although the …

It is currently understood that in order for a tumor to successfully grow, it must evolve means
of evading immune surveillance. In the past several decades, researchers have leveraged …

The successful clinical application of immune checkpoint blockade (ICB) and chimeric
antigen receptor T cells (CAR-T) therapeutics has attracted extensive attention to …

Cancer immunotherapy harnesses the immune system to attack tumors and has received
extensive attention in recent years. Cancer vaccines as an important branch of …